PosiFunda · Fundamentals

Retension Pharmaceuticals, Inc.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (4)

Retension Pharmaceuticals, Inc. made a loss over the last year.

Compared with Healthcare companies in United States.

P/E ratio

Loss

Retension Pharmaceuticals, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

-0.84

Retension Pharmaceuticals, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.

Market cap

$129 M

The total market value of all of Retension Pharmaceuticals, Inc.'s shares at today's price (share price × number of shares), smaller than 63% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Dividend yield

None

Retension Pharmaceuticals, Inc. does not currently pay a dividend.

Questions

Does Retension Pharmaceuticals, Inc. pay a dividend?

No. Retension Pharmaceuticals, Inc. does not currently pay a dividend.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.